Avutometinib
About
Therapy type: Targeted therapy
Therapy strategy: MEK inhibition, RAF inhibition
Mappings
NCI Thesaurus: Avutometinib (ncit:C80060)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.
| Organization(s) | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| FDA (1) | KRAS p.G12C | Low-Grade Serous Ovarian Cancer | Avutometinib, Defactinib | |
| FDA (1) | KRAS p.G12V | Low-Grade Serous Ovarian Cancer | Avutometinib, Defactinib |